Lexaria Bioscience Corp. - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on April 11, 2008, by Lexaria Corp. (also referred to as Lexaria Bioscience Corp. in metadata). The report discloses the entry into a material definitive agreement on April 10, 2008, regarding the potential acquisition of oil and gas assets.
Key Financial Metrics
The filing does not provide standard financial statements, revenue, profit, cash flow, or debt metrics. The only financial figures disclosed relate to the specific transaction:
- Option Consideration: $25,000 paid to secure the option.
- Potential Purchase Price: $4,500,000 payable upon exercise of the option.
Material Changes and Transaction Details
The Company entered into an exclusive, irrevocable option agreement with John and Gwen Deakle to purchase a 50% working interest in the Palmetto Point and Belmont Lake oil and gas fields located in Adams and Wilkinson Counties, Mississippi. The assets include 13 specific wells and associated leases. The option period is 60 days from the agreement date.
Outlook, Risks, and Contingencies
The closing of the transaction is contingent upon the Company securing financing to fund the $4,500,000 purchase price. Management explicitly states there can be no assurances that the Option Agreement will close in accordance with its terms. No other guidance or risk factors regarding general operations are provided in this filing.
Key Facts for Investor Verification
- Verify the Company's current liquidity and ability to secure the $4.5 million financing required to exercise the option.
- Confirm the status of the 13 identified wells (F-40, F-118, F-121, F-7, F-39, F-42, F-36-2, F-4, F-29, F-12-1, F-6B, F-52A, F-12-3) and their production status.
- Monitor whether the option is exercised within the 60-day window or if the $25,000 consideration is forfeited.